The exploration of the deep-sea realm has unveiled two novel marine actinobacterial strains, MA3_2.13 and S07_1.15, isolated from the depths of the Madeira archipelago in the NE Atlantic Ocean. By employing a hybrid sequencing strategy combining Illumina and PacBio technologies, the genomes of these isolates were de novo assembled, revealing intriguing insights into their biosynthetic potential for natural products. Phylogenetic analyses positioned MA3_2.13 as a new species within the Streptomyces genus, while S07_1.15 appeared closely related to Streptomyces xinghaiensis.
Traditionally, natural products derived from microorganisms have been instrumental in drug discovery, but the advent of genomic technologies has revolutionized the identification of novel bioactive compounds. Streptomyces bacteria, in particular, are known to harbor a vast reservoir of biosynthetic gene clusters (BGCs) in their genomes, hinting at untapped potential for novel natural products. Genome mining of these isolates from the deep sea revealed a high percentage of BGCs, with MA3_2.13 showing promise for the production of new metabolites.
Genome sequencing and in silico analysis are crucial for unveiling the biosynthetic capabilities of microbial isolates. The use of hybrid strategies combining short-read and long-read sequencing technologies ensures high-quality genome assemblies, essential for accurate prediction of BGCs. In the case of these deep-sea Streptomyces isolates, the genome mining efforts highlighted multiple BGCs with the potential to encode novel secondary metabolites, offering a glimpse into the diverse chemical repertoire of these bacteria.
The genomic features of isolates MA3_2.13 and S07_1.15 were meticulously characterized, shedding light on their metabolic profiles and adaptations to the deep-sea environment. Noteworthy findings included the presence of metabolic genes linked to ion transport, transcriptional regulation, and secondary metabolite biosynthesis, indicating unique metabolic features that could lead to the production of bioactive compounds. The identification of putative genomic islands and prophage regions added another layer of complexity to the genomic landscape of these isolates.
In-depth phylogenetic analyses confirmed the novelty of MA3_2.13 as a distinct Streptomyces species, while S07_1.15 showed close relatedness to S. xinghaiensis. The exploration of marine adaptation genes in the genomes of these isolates revealed potential mechanisms for thriving in the deep-sea environment. Furthermore, the secondary metabolism in silico profiling unveiled a plethora of biosynthetic gene clusters, some of which displayed similarities to known clusters encoding bioactive compounds, while others hinted at the production of novel chemical entities.
Overall, the comprehensive genome sequencing and biosynthetic potential evaluation of these deep-sea Streptomyces isolates from the Madeira archipelago provide a foundation for further investigations into their biotechnological applications. The discovery of novel natural products from these unexplored microbial sources holds promise for drug discovery and bioprospecting efforts, emphasizing the importance of genomic-driven approaches in unlocking the hidden potential of marine actinobacteria.
Key Takeaways:
– Deep-sea Streptomyces isolates MA3_2.13 and S07_1.15 from the Madeira archipelago exhibit unique genomic features and biosynthetic potential for natural products.
– Genome sequencing and in silico analysis reveal a high percentage of biosynthetic gene clusters in these isolates, hinting at the production of novel bioactive compounds.
– Phylogenetic analyses confirm the novelty of MA3_2.13 as a new Streptomyces species and highlight the close relationship of S07_1.15 to S. xinghaiensis.
– The exploration of marine adaptation genes and secondary metabolism profiles provides insights into the metabolic capabilities and environmental adaptations of these deep-sea Streptomyces isolates.
Tags: downstream, yeast, quality control, bioinformatics
Read more on pmc.ncbi.nlm.nih.gov